How much funding has Shattuck Labs raised?

Shattuck Labs has raised $221.0M in total funding, most recently a Series B round.

Who are Shattuck Labs's investors?

Shattuck Labs's investors include Redmile Group, OrbiMed, Janus Henderson Investors, Hatteras Venture Partners, Fidelity Management.

When was Shattuck Labs founded?

Shattuck Labs was founded in 2016.

Where is Shattuck Labs headquartered?

Shattuck Labs is headquartered in Austin, Texas, United States.

What industry is Shattuck Labs in?

Shattuck Labs operates in Biotech, Healthcare.

How many employees does Shattuck Labs have?

Shattuck Labs has 51-200 employees.

Shattuck Labs

IPO

Advancing DR3-targeting therapies for IBD and beyond.

Public · Austin, United States · Founded 2016 · $221.0M raised

Biotech

Healthcare

Headquarters: Austin, Texas
Employees: 51–200
Founded: 2016
Business Model: B2B
Website: shattucklabs.com

Total Funding: $221.0M
Last Round: $118.0M Series BAug 2025
Rounds: 2
Type: Public

About

Shattuck Labs (NASDAQ: STTK) is a clinical-stage biotechnology company developing novel DR3-targeting biologic therapies for inflammatory and immune-mediated diseases. Its lead program, SL-325, is a potentially first-in-class DR3 blocking antibody in Phase 1 development for inflammatory bowel disease. Founded in 2016 and headquartered in Austin, Texas.

Summary

Shattuck Labs is a Biotech company based in Austin, United States, founded in 2016. It has raised $221.0M in total across 2 rounds, most recently a $118.0M Series B round in Aug 2025. Investors include Redmile Group, OrbiMed and Janus Henderson Investors.

LinkedIn X (Twitter)